Search results for

PTAB Data and Analysis: Managing IP reveals Patent Trial and Appeal Board filing data for June and analyses recent decisions from the Supreme Court, Federal Circuit and PTAB, including the Board interpreting Enfish in mixed rulings. The USPTO has also announced it is replacing the Patent Review Processing System for PTAB trials

Following the UK Supreme Court’s judgment in the Trunki design dispute, Managing IP summarises practical tips from UK practitioners on filing designs and eight lessons from the judgment

Following the retirement of INTA executive director Alan Drewsen this summer, Spanish-born Etienne Sanz de Acedo will take over as chief executive officer from July 1. At present Sanz de Acedo is head of communications for OHIM. He spoke to Alli Pyrah about his goals for INTA and the challenges that lie ahead. My mother is French and my dad, who passed away, was Spanish. I started learning English at school and went to the UK many times during the summertime to practice. At OHIM, it was advantageous to be able to speak as many languages as possible. I had a passion for Italian so I spent five summers going to Italy and learning Italian.

Hogan Lovells has increased its IP presence in Silicon Valley and San Francisco with five lateral hires

Argentina

Allen & Overy partner Colleen Keck has been appointed deputy chair of the UK Copyright Tribunal by the Lord Chancellor Kenneth Clarke.

Brazil has thrown off its poor reputation for protecting trade marks. Rodrigo Caiuby Novaes, of Clarke, Modet & Co in Rio de Janeiro, reveals how the new industrial property law has transformed registration practice

Austria

The shortlist for the sixth annual Euromoney Legal Media Group Europe Women in Business Law Awards has been announced. For the 2016 nominees, please see below.

Managing IP analyses the busiest companies and law firms at the Patent Trial and Appeal Board so far this year, using Docket Navigator. The first half was notable for petitions from automotive companies and the Coalition for Affordable Drugs, while an Acacia Research subsidiary was the most targeted entity